New research indicates that patients who come off blockbuster weight-loss injections like semaglutide or tirzepatide can put back on reduced body mass far faster than those who end traditional diet and exercise plans.
Findings released in a leading medical journal shows that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using such medications must be aware of the risk of rapid weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb.
That rate of regain means a return to pre-treatment mass in about one and a half years.
Weighing Therapies
The analysis, which looked at dozens of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers point out that people who lose weight through dieting generally see a less rapid weight regain—perhaps 100 grams monthly—post-intervention.
Understanding the Fast Regain
Doctors suggest the mechanism of the jabs accounts for the accelerated weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Artificially providing GLP-1 concentrations far above than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this medication results in appetite is uncontrolled, making binge eating a significant risk."
A Lifelong Disease?
The NHS advise the injections for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Many experts contend that, considering the significant potential of weight regain, the treatment should be considered ongoing.
This opinion is supported by pharmaceutical companies, who say that the findings "highlight the long-term character of excess weight," akin to managing conditions like diabetes.
User Accounts
Individuals who have stopped the jabs explain a sudden return of appetite.
"I experienced a trigger flipping and you're instantly extremely hungry," said a patient.
This difficulty is exacerbated if users have not adopted lasting dietary or behavioural modifications during therapy.
Growing Interest
Figures indicate that millions of adults in the UK have tried these injections in the last 12 months, with demand continuing to grow.
- Adoption is greater among women compared to males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the medications through private healthcare rather than public health services.
Finally, clinicians stress that while these medications are powerful tools for shedding pounds, they are not a standalone solution and lasting health benefits likely depends on integrated behavioural management.
